9 employees
Tarsier Pharma is a late clinical-stage company that develops treatment for autoimmune and inflammatory ocular diseases.
2016
$3M
from 1 investors over 1 rounds
Tarsier Pharma raised $3M on September 10, 2018
Investors: SUN PHARMA